The European Association for the study of Obesity (EASO) and the Novo Nordisk Foundation have collaborated in awarding the EASO – Novo Nordisk Foundation Obesity Prize for Excellence and the EASO – Novo Nordisk Foundation New Investigator Award at the annual European Congress on Obesity (ECO). An Assessment Committee appointed by the EASO decides the recipients of the Prize and the Awards, and the Novo Nordisk Foundation funds the grant accompanying the Prize and Awards.
The EASO-Novo Nordisk Foundation Obesity Prize for Excellence is awarded to recognize outstanding research or technology contributions to the understanding of obesity, its etiology, its complications and its prevention and management. The Prize is accompanied by DKK 2 million, of which 300,000 is a personal award and DKK 1.7 million for research purposes.
The Prize winner is selected based on the following selection criteria:
- International recognition as a researcher that has contributed significantly to obesity research.
- Recipient must be employed by a university, hospital or other non-profit institution to be considered.
The EASO-Novo Nordisk Foundation New Investigator Award is awarded for promising research in the field of obesity. The Awards are awarded within Basic Science, Clinical Research, Public Health and Childhood Obesity. Each of these awards are accompanied by DKK 300,000 for research purposes.
The Award winners are selected based on the following selection criteria:
- Excellence and clear commitment to their chosen area of obesity research.
- PhD within the past five years or MD within the past eight years.
- Recipients must be employed at a university, hospital or another non-profit institution in Europe (for the past year).
The EASO President Jason Halford said “We are delighted to have the opportunity to partner with the Novo Nordisk Foundation to support these five research-focused annual grants per year for three years [2023-2025]”.
Scientific excellence
Globally, more than 1 billion people live with obesity, and this number is expected to increase to 4 billion people by 2035.
With the establishment of the Prize, the Novo Nordisk Foundation also strives to reward and encourage individual scientific excellence in order to promote innovative research that can lead to new knowledge about obesity for the benefit of people who live with obesity and stimulate interest in science and technology in society as a whole.
Further information
Alexandra Søgaard Helbo
[email protected]
